Impact of Optimal Medical Therapy on Reintervention and Survival Rates after Endovascular Infrapopliteal Revascularization
Within this single-center cohort study, we investigated the impact of optimal medical therapy on all-cause mortality, major amputation-free survival and clinically driven target lesion revascularization (CD TLR) in 552 patients with peripheral arterial disease (PAD) undergoing endovascular infrapopl...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-08-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/12/15/5146 |
| _version_ | 1797586551880810496 |
|---|---|
| author | Tim Wittig Toni Pflug Andrej Schmidt Dierk Scheinert Sabine Steiner |
| author_facet | Tim Wittig Toni Pflug Andrej Schmidt Dierk Scheinert Sabine Steiner |
| author_sort | Tim Wittig |
| collection | DOAJ |
| description | Within this single-center cohort study, we investigated the impact of optimal medical therapy on all-cause mortality, major amputation-free survival and clinically driven target lesion revascularization (CD TLR) in 552 patients with peripheral arterial disease (PAD) undergoing endovascular infrapopliteal revascularization. From the overall cohort, 145 patients were treated for intermittent claudication (IC) and 407 were treated for critical limb ischemia (CLI). Optimal medical therapy (OMT) was defined as the presence of at least one antiplatelet agent, statin and ACE inhibitor or AT-2 antagonist based on guideline recommendations. About half (55.5%) of all patients were prescribed OMT at discharge, with a higher proportion in claudicants (62.1%) versus CLI patients (53.2%). Over three years of follow-up, survival was significantly better in patients with IC (80.6 ± 3.8% vs. 59.9 ± 2.9%; <i>p</i> < 0.001). There was a signal towards better survival in those patients receiving OMT (log-rank <i>p</i> = 0.09). Similarly, amputation-free survival (AFS) was significantly better in patients with IC (<i>p</i> = 0.004) and also in patients receiving OMT (78.8 ± 3.6%) compared to that in those without OMT (71.5 ± 4.2%; <i>p</i> = 0.046). Freedom from CD TLR within three years was significantly better in the IC group (<i>p</i> = 0.002), but there were no statistically significant differences for CD TLR dependent on the presence of OMT (<i>p</i> = 0.79). In conclusion, there is still an important underuse of OMT in patients undergoing infrapopliteal interventions, which is even more pronounced in CLI despite a signal for its benefit regarding all-cause mortality and major amputation-free survival. |
| first_indexed | 2024-03-11T00:23:49Z |
| format | Article |
| id | doaj.art-c884fd0ee56b4917b8a7e11c048d3878 |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-11T00:23:49Z |
| publishDate | 2023-08-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-c884fd0ee56b4917b8a7e11c048d38782023-11-18T23:09:59ZengMDPI AGJournal of Clinical Medicine2077-03832023-08-011215514610.3390/jcm12155146Impact of Optimal Medical Therapy on Reintervention and Survival Rates after Endovascular Infrapopliteal RevascularizationTim Wittig0Toni Pflug1Andrej Schmidt2Dierk Scheinert3Sabine Steiner4Department of Angiology, University Hospital Leipzig, 04103 Leipzig, GermanyDepartment of Vascular Surgery, Sana Klinikum Borna, 04552 Borna, GermanyDepartment of Angiology, University Hospital Leipzig, 04103 Leipzig, GermanyDepartment of Angiology, University Hospital Leipzig, 04103 Leipzig, GermanyDepartment of Angiology, University Hospital Leipzig, 04103 Leipzig, GermanyWithin this single-center cohort study, we investigated the impact of optimal medical therapy on all-cause mortality, major amputation-free survival and clinically driven target lesion revascularization (CD TLR) in 552 patients with peripheral arterial disease (PAD) undergoing endovascular infrapopliteal revascularization. From the overall cohort, 145 patients were treated for intermittent claudication (IC) and 407 were treated for critical limb ischemia (CLI). Optimal medical therapy (OMT) was defined as the presence of at least one antiplatelet agent, statin and ACE inhibitor or AT-2 antagonist based on guideline recommendations. About half (55.5%) of all patients were prescribed OMT at discharge, with a higher proportion in claudicants (62.1%) versus CLI patients (53.2%). Over three years of follow-up, survival was significantly better in patients with IC (80.6 ± 3.8% vs. 59.9 ± 2.9%; <i>p</i> < 0.001). There was a signal towards better survival in those patients receiving OMT (log-rank <i>p</i> = 0.09). Similarly, amputation-free survival (AFS) was significantly better in patients with IC (<i>p</i> = 0.004) and also in patients receiving OMT (78.8 ± 3.6%) compared to that in those without OMT (71.5 ± 4.2%; <i>p</i> = 0.046). Freedom from CD TLR within three years was significantly better in the IC group (<i>p</i> = 0.002), but there were no statistically significant differences for CD TLR dependent on the presence of OMT (<i>p</i> = 0.79). In conclusion, there is still an important underuse of OMT in patients undergoing infrapopliteal interventions, which is even more pronounced in CLI despite a signal for its benefit regarding all-cause mortality and major amputation-free survival.https://www.mdpi.com/2077-0383/12/15/5146peripheral arterial diseasechronic limb-threatening ischemialimb salvagemajor amputationpharmacotherapy |
| spellingShingle | Tim Wittig Toni Pflug Andrej Schmidt Dierk Scheinert Sabine Steiner Impact of Optimal Medical Therapy on Reintervention and Survival Rates after Endovascular Infrapopliteal Revascularization Journal of Clinical Medicine peripheral arterial disease chronic limb-threatening ischemia limb salvage major amputation pharmacotherapy |
| title | Impact of Optimal Medical Therapy on Reintervention and Survival Rates after Endovascular Infrapopliteal Revascularization |
| title_full | Impact of Optimal Medical Therapy on Reintervention and Survival Rates after Endovascular Infrapopliteal Revascularization |
| title_fullStr | Impact of Optimal Medical Therapy on Reintervention and Survival Rates after Endovascular Infrapopliteal Revascularization |
| title_full_unstemmed | Impact of Optimal Medical Therapy on Reintervention and Survival Rates after Endovascular Infrapopliteal Revascularization |
| title_short | Impact of Optimal Medical Therapy on Reintervention and Survival Rates after Endovascular Infrapopliteal Revascularization |
| title_sort | impact of optimal medical therapy on reintervention and survival rates after endovascular infrapopliteal revascularization |
| topic | peripheral arterial disease chronic limb-threatening ischemia limb salvage major amputation pharmacotherapy |
| url | https://www.mdpi.com/2077-0383/12/15/5146 |
| work_keys_str_mv | AT timwittig impactofoptimalmedicaltherapyonreinterventionandsurvivalratesafterendovascularinfrapoplitealrevascularization AT tonipflug impactofoptimalmedicaltherapyonreinterventionandsurvivalratesafterendovascularinfrapoplitealrevascularization AT andrejschmidt impactofoptimalmedicaltherapyonreinterventionandsurvivalratesafterendovascularinfrapoplitealrevascularization AT dierkscheinert impactofoptimalmedicaltherapyonreinterventionandsurvivalratesafterendovascularinfrapoplitealrevascularization AT sabinesteiner impactofoptimalmedicaltherapyonreinterventionandsurvivalratesafterendovascularinfrapoplitealrevascularization |